| Company Name: |
Chengdu Pukang Biotechnology Co., Ltd
|
| Tel: |
028-82550498 19102685862 |
| Email: |
sales@pu-kang.com |
| Products Intro: |
Product Name:Benzyl-PEG7-amine
CAS:868594-43-8
Purity:95% Package:1g,5g,10g
|
Benzyl-PEG7-amino manufacturers
- Benzyl-PEG7-NH2
-
- $0.00 / 1g
-
2024-03-25
- CAS:868594-43-8
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| | Benzyl-PEG7-amino Basic information |
| Product Name: | Benzyl-PEG7-amino | | Synonyms: | Benzyl-PEG7-amino;Benzyl-PEG6-amino;Benzyl-PEG6-amine;Benzyl-PEG7-amine;H2N-(CH2CH2O)7-Bn;20-(phenylmethyloxy)-3,6,9,12,15,18-hexaoxaeicosylamine;Benzyl-PEG7-NH2;3,6,9,12,15,18,21-Heptaoxadocosan-1-amine, 22-phenyl- | | CAS: | 868594-43-8 | | MF: | C21H37NO7 | | MW: | 415.52 | | EINECS: | | | Product Categories: | | | Mol File: | 868594-43-8.mol |  |
| | Benzyl-PEG7-amino Chemical Properties |
| | Benzyl-PEG7-amino Usage And Synthesis |
| Biological Activity | Benzyl-PEG7-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | Benzyl-PEG7-amino Preparation Products And Raw materials |
|